Bivalent Meningococcal Vaccine

Known as: Meningococcal Vaccine, Bivalent 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2018
012320132018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Bivalent rLP2086 (Trumenba), a vaccine for prevention of Neisseria meningitidis serogroup B (NmB) disease, was licensed for use… (More)
Is this relevant?
2017
2017
OBJECTIVES Bivalent rLP2086 (Trumenba®; MenB-FHbp), composed of two factor H binding proteins (FHbps), is a vaccine approved in… (More)
Is this relevant?
2017
2017
BACKGROUND Bivalent rLP2086 is a recombinant factor H binding protein-based vaccine approved in the USA for prevention of… (More)
Is this relevant?
2016
2016
BACKGROUND This study in healthy adolescents (11 to <18 years) evaluated coadministration of quadrivalent human papillomavirus… (More)
Is this relevant?
2016
2016
BACKGROUND Bivalent rLP2086, targeting meningococcal serogroup B, will extend prevention of meningococcal disease beyond that… (More)
Is this relevant?
Review
2016
Review
2016
Neisseria meningitidis is a common cause of bacterial meningitis, often leading to permanent sequelae or death. N. meningitidis… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2013
2013
The present study demonstrates the cross-protective efficacy of baculovirus displayed HAs of A/Indonesia/669/06 and A/Anhui/01/05… (More)
Is this relevant?